News & Events

Webinar: Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies

Our webinar “Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies" was live at 12:00 PM EST on Nov…

Read more
Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti- CD40 mAb) Phase I Trial at ESMO 2023

Beijing, China, Oct 16, 2023 - Eucure Biopharma, a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), will attend and present…

Read more
Visit our Booth and Bispecific ADC Posters at World ADC San Diego: Oct 17-18

Biocytogen’s BD team is excited to exhibit and attend the 14th Annual World ADC San Diego conference, taking place from Oct 17–18, 2023! Be sure…

Read more
Webinar: Predicting Toxicity of Immuno-Oncology Drug Candidates: Preclinical Platforms to Evaluate Toxicology In Vivo and Ex Vivo

Our webinar “Predicting Toxicity of Immuno-Oncology Drug Candidates: Preclinical Platforms to Evaluate Toxicology In Vivo and Ex Vivo" was live at 12:00 PM EDT on Oct…

Read more
Join us at the Festival of Biologics Europe 2023: Oct 10-12

Join us at the Festival of Biologics Europe 2023 in Basel, Switzerland from Oct 10-12! Stop by booth #703 and learn about our preclinical animal…

Read more
Complimentary Pair of Genetically Modified Mice – Valentine’s Day Special Offer

This Valentines day, receive a complimentary breeding pair of genetically modified mice with Biocytogen's gene targeting services. Hurry up– our offer is valid only until…

Read more
Don’t Miss Our Presentation and Booth at BioJapan 2023!

Biocytogen’s Asia-Pacific business development team is pleased to present and exhibit at BioJapan 2023, taking place from October 11-13, 2023 in Yokohama, Japan!  Dr. Jie…

Read more
Biocytogen Officially Launches RenMice® Series

Fully Human Antibody and TCR Mouse Models Showcase Biocytogen's Capabilities to Innovate the Discovery of Novel Biologic Drugs Beijing, China, September 15, 2023 – Biocytogen…

Read more
Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development

Beijing, China, September 7, 2023 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery of novel antibody…

Read more
Free Trial of Humanized Animal Models – 5 Free Humanized KnockIn Mice Offer!

This promotion has ended, please check out our Humanized Animal Models and Cell lines instead. New Year. New Research Opportunities.   Our Therapeutic Focus Biocytogen's…

Read more
Back to top
WordPress Double Opt-in by Forge12